OSMT - Osmotica Pharmaceuticals plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
245,817
263,701
245,749
218,460
Cost of Revenue
121,678
135,014
125,188
125,616
Gross Profit
124,138
128,687
120,561
92,844
Operating Expenses
Research Development
43,066
48,761
42,688
29,062
Selling General and Administrative
94,872
74,243
56,955
65,958
Total Operating Expenses
137,939
123,004
99,643
95,020
Operating Income or Loss
-13,800
5,683
20,918
-2,176
Interest Expense
18,951
20,791
29,052
20,187
Total Other Income/Expenses Net
-351,424
-103,557
-77,508
-29,704
Income Before Tax
-384,175
-118,664
-85,643
-52,067
Income Tax Expense
-33,194
-9,268
-40,488
-10,246
Income from Continuing Operations
-350,981
-109,396
-45,155
-41,821
Net Income
-350,981
-109,396
-45,155
-41,821
Net Income available to common shareholders
-350,981
-109,396
-41,938
-41,821
Reported EPS
Basic
-
-2.42
-0.98
-0.98
Diluted
-
-2.42
-0.98
-0.98
Weighted average shares outstanding
Basic
-
45,276
42,851
42,851
Diluted
-
45,276
42,851
42,851
EBITDA
-
-16,301
-10,140
-8,295